Couverture de JAMA Medical News

JAMA Medical News

JAMA Medical News

De : JAMA Network
Écouter gratuitement

À propos de ce contenu audio

 Discussions of timely topics in clinical medicine, biomedical research, public health, health policy, and more, featured in the Medical News section of JAMA, the Journal of the American Medical Association.2024 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies. Hygiène et vie saine Maladie et pathologies physiques Science
Épisodes
  • Treating Methamphetamine Use Disorder With an Antidepressant

    Treating Methamphetamine Use Disorder With an Antidepressant
    Apr 24 2026

    JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Could a Common Antidepressant Help Treat Methamphetamine Use Disorder?"

    Related Content:

    • Could a Common Antidepressant Help Treat Methamphetamine Use Disorder?
    Afficher plus Afficher moins
    4 min
  • Cicada, the SARS-CoV-2 Variant With a Surprising Trajectory

    Cicada, the SARS-CoV-2 Variant With a Surprising Trajectory
    Apr 17 2026

    JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring."

    Related Content:

    • What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring
    Afficher plus Afficher moins
    6 min
  • Highlights From the American College of Cardiology's 2026 Scientific Sessions

    Highlights From the American College of Cardiology's 2026 Scientific Sessions
    Apr 10 2026

    Hear the latest on PCSK9 inhibitors, cardiorenal benefits of GLP-1 drugs, and other clinical research in this interview with Katie Berlacher, MD, MS, chair of this year's annual ACC meeting.

    Related Content:

    • PCSK9 Inhibitors in Diabetes, Tirzepatide's Cardiorenal Effects, Shingles Vaccine, and More From ACC
    Afficher plus Afficher moins
    21 min
Aucun commentaire pour le moment